Balanced news tone
News Sentiment
FME sentiment intelligence
Fresenius Medical Care AG news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Weighted score
50
Balanced news tone
35 relevant articles
News tone and price action are not far from neutral.
81/100 classification confidence.
directly relevant articles
high-authority source matches
+2.6% over one week, +9.2% over four weeks, trend inactive, and near fair-value range.
Fresenius Medical Care Stock - Sunday background on the dialysis specialist
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Primary event
Market update
81/100 classification
One-week reaction
2.6%
Price confirming higher
Trend fit
Trend inactive
9.2% over four weeks
Fair value
6.5%
Near fair-value range
Sentiment Mix
Positive, neutral, negative
Positive
4
Neutral
27
Negative
4
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
Above 50
Neutral zone
Below 50
News Tape
Relevant headlines
AD HOC NEWS
Direct company coverage
Fresenius Medical Care Stock - Sunday background on the dialysis specialist
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 21 Jun 2026 11:47
- Source
- AD HOC NEWS
AD HOC NEWS
Direct company coverage
Fresenius Stock - Sunday background on balance-sheet reset and health-care exposure
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 21 Jun 2026 11:43
- Source
- AD HOC NEWS
AD HOC NEWS
Direct company coverage
Fresenius Medical Care Stock - Long-term dialysis strategy in focus
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 20 Jun 2026 20:57
- Source
- AD HOC NEWS
AD HOC NEWS
Direct company coverage
Fresenius Stock - Weekly review and sector comparison after quiet news flow
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 19 Jun 2026 13:01
- Source
- AD HOC NEWS
AD HOC NEWS
Direct company coverage
Fresenius Medical Care Stock (DE0005785802): Shares trade near EUR 40.90 after a modest Xetra gain
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 16 Jun 2026 20:12
- Source
- AD HOC NEWS
simplywall.st
Direct company coverage
A Look At Fresenius Medical Care (XTRA:FME) Valuation As Kinexus Expands Its Digital Kidney Care Platform
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 10 Jun 2026 07:00
- Source
- simplywall.st
AD HOC NEWS
Direct company coverage
Fresenius Medical Care stock (DE0005785802): focus shifts after refinancing and strategic review
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 09 Jun 2026 07:00
- Source
- AD HOC NEWS
AD HOC NEWS
Direct company coverage
Fresenius Medical Care stock (DE0005785802): Transformation after NYSE delisting and Q1 results
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 08 Jun 2026 07:00
- Source
- AD HOC NEWS
Seeking Alpha
Direct company coverage
Medical device and healthcare services stocks lead sector's EPS revision rankings (XLV:NYSEARCA)
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 02 Jun 2026 07:00
- Source
- Seeking Alpha
Market source
Direct company coverage
Assessing Fresenius Medical Care (XTRA:FME) Valuation After Recent Share Price Weakness
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 29 May 2026 07:00
- Source
- Market source
Stock Titan
Direct company coverage
Fresenius Medical Care (FMS) starts EUR 1B share buyback with EUR 600M first tranche
- Tone
- Positive 62/100
- Event
- Capital return
- Published
- 28 May 2026 07:00
- Source
- Stock Titan
TradingView
Direct company coverage
Fresenius Medical Care announces new share buyback program with a total volume of around EUR 1 billion with phased execution over 12 months
- Tone
- Positive 62/100
- Event
- Capital return
- Published
- 26 May 2026 07:00
- Source
- TradingView
TradingView
Direct company coverage
Fresenius Medical Care Reappoints Chief Financial Officer Martin Fischer
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 20 May 2026 07:00
- Source
- TradingView
Market source
Direct company coverage
Just Four Days Till Fresenius Medical Care AG (ETR:FME) Will Be Trading Ex-Dividend
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 17 May 2026 07:00
- Source
- Market source
simplywall.st
Direct company coverage
Fresenius Medical Care's (ETR:FME) Earnings Offer More Than Meets The Eye
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 14 May 2026 07:00
- Source
- simplywall.st
Market source
Direct company coverage
Fresenius Medical Care's (ETR:FME) Solid Earnings Have Been Accounted For Conservatively
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 13 May 2026 07:00
- Source
- Market source
Seeking Alpha
Direct company coverage
Fresenius Medical: The Undervaluation Is Getting Clearer (NYSE:FMS)
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 05 May 2026 07:00
- Source
- Seeking Alpha
simplywall.st
Direct company coverage
Is Fresenius Medical Care’s Symvess Realignment Shaping a New Vascular Access Strategy for (XTRA:FME)?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 05 May 2026 07:00
- Source
- simplywall.st
Stock Titan
Direct company coverage
Humacyte (HUMA) takes ex-U.S. Symvess control as Fresenius retains 8.4% stake
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 27 Apr 2026 07:00
- Source
- Stock Titan
simplywall.st
Direct company coverage
Is Fresenius Medical Care (XTRA:FME) Now Appealing After Years Of Share Price Weakness
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 25 Apr 2026 07:00
- Source
- simplywall.st
Market source
Direct company coverage
Is Fresenius Medical Care (XTRA:FME) Now Attractively Priced After Years Of Share Price Weakness?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 07 Apr 2026 07:00
- Source
- Market source
newsline.com
Direct company coverage
MPT Stock Analysis: Medical Properties Trust Inc. common stock $4.63, slight healthcare sector dip
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 03 Apr 2026 07:00
- Source
- newsline.com
Market source
Direct company coverage
Fresenius Medical Care AG (FMS) Looks to Improve Profitability After Smashing Q4 Expectations
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 13 Mar 2026 07:00
- Source
- Market source
marketscreener.com
Direct company coverage
German DAX Index Down; Fresenius Medical Care Shares Fall on Muted Outlook
- Tone
- Negative 22/100
- Event
- Guidance
- Published
- 24 Feb 2026 08:00
- Source
- marketscreener.com
Market source
Direct company coverage
The five-year loss for Fresenius Medical Care (ETR:FME) shareholders likely driven by its shrinking earnings
- Tone
- Negative 34/100
- Event
- Earnings
- Published
- 10 Feb 2026 08:00
- Source
- Market source
Market source
Direct company coverage
A Look At Fresenius Medical Care (XTRA:FME) Valuation After Recent Share Price Weakness
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 24 Jan 2026 08:00
- Source
- Market source
Market source
Direct company coverage
Will Fresenius Medical Care's (XTRA:FME) Accelerated €1 Billion Buyback Redefine Its Capital Return Narrative?
- Tone
- Neutral 50/100
- Event
- Capital return
- Published
- 09 Jan 2026 08:00
- Source
- Market source
simplywall.st
Direct company coverage
Fresenius Medical Care AG (ETR:FME) Stock's On A Decline: Are Poor Fundamentals The Cause?
- Tone
- Negative 34/100
- Event
- Market update
- Published
- 28 Nov 2025 08:00
- Source
- simplywall.st
TIKR.com
Direct company coverage
Fresenius SE’s 2027 Stock Outlook: What’s Next for the German Healthcare Leader?
- Tone
- Neutral 50/100
- Event
- Guidance
- Published
- 11 Nov 2025 08:00
- Source
- TIKR.com
Reuters
Direct company coverage
Fresenius lifts revenue guidance, to sell FMC shares to maintain stake
- Tone
- Negative 34/100
- Event
- Earnings
- Published
- 05 Aug 2025 07:00
- Source
- Reuters